Published in Biophys J on August 01, 1995
ApoE promotes the proteolytic degradation of Abeta. Neuron (2008) 4.75
On the nucleation and growth of amyloid beta-protein fibrils: detection of nuclei and quantitation of rate constants. Proc Natl Acad Sci U S A (1996) 4.75
Kinetic theory of fibrillogenesis of amyloid beta-protein. Proc Natl Acad Sci U S A (1997) 3.40
A mathematical model of the kinetics of beta-amyloid fibril growth from the denatured state. Biophys J (2001) 1.96
Molecular dynamics simulation of amyloid beta dimer formation. Biophys J (2004) 1.63
Ultrastructural organization of amyloid fibrils by atomic force microscopy. Biophys J (2000) 1.46
Structure-function relationships of pre-fibrillar protein assemblies in Alzheimer's disease and related disorders. Curr Alzheimer Res (2008) 1.26
Apolipoprotein E promotes β-amyloid trafficking and degradation by modulating microglial cholesterol levels. J Biol Chem (2011) 1.23
Effect of dehydration on the aggregation kinetics of two amyloid peptides. J Phys Chem B (2009) 1.14
Smart Polymeric Gels: Redefining the Limits of Biomedical Devices. Prog Polym Sci (2007) 1.11
Loss of metal ions, disulfide reduction and mutations related to familial ALS promote formation of amyloid-like aggregates from superoxide dismutase. PLoS One (2009) 1.11
Abeta aggregation and possible implications in Alzheimer's disease pathogenesis. J Cell Mol Med (2009) 1.09
Insertion of Alzheimer's A beta 40 peptide into lipid monolayers. Biophys J (2004) 0.99
Beta-amyloid peptide blocks the fast-inactivating K+ current in rat hippocampal neurons. Biophys J (1996) 0.96
Concentration effect on the aggregation of a self-assembling oligopeptide. Biophys J (2003) 0.93
A kinetic model for beta-amyloid adsorption at the air/solution interface and its implication to the beta-amyloid aggregation process. J Phys Chem B (2009) 0.90
Combined effects of agitation, macromolecular crowding, and interfaces on amyloidogenesis. J Biol Chem (2012) 0.85
Mechanism of accelerated assembly of beta-amyloid filaments into fibrils by KLVFFK(6). Biophys J (2004) 0.84
Exploration of the mechanism for LPFFD inhibiting the formation of beta-sheet conformation of A beta(1-42) in water. J Mol Model (2010) 0.84
Structure of A beta(25-35) peptide in different environments. Biophys J (2004) 0.83
Comparative studies on peptides representing the so-called tachykinin-like region of the Alzheimer Abeta peptide [Abeta(25-35)]. Biochem J (1998) 0.82
Enrichment of amyloidogenesis at an air-water interface. Biophys J (2012) 0.82
Ammonium hydroxide treatment of Aβ produces an aggregate free solution suitable for biophysical and cell culture characterization. PeerJ (2013) 0.81
Structural characterization of apomyoglobin self-associated species in aqueous buffer and urea solution. Biophys J (2005) 0.80
Combined Liver X Receptor/Peroxisome Proliferator-activated Receptor γ Agonist Treatment Reduces Amyloid β Levels and Improves Behavior in Amyloid Precursor Protein/Presenilin 1 Mice. J Biol Chem (2015) 0.79
A modified Stokes-Einstein equation for Aβ aggregation. BMC Bioinformatics (2011) 0.77
Dynamics of the formation of a hydrogel by a pathogenic amyloid peptide: islet amyloid polypeptide. Sci Rep (2016) 0.77
Reversal of temperature-induced conformational changes in the amyloid-beta peptide, Abeta40, by the beta-sheet breaker peptides 16-23 and 17-24. Br J Pharmacol (2009) 0.77
Amyloid-like assembly of the low complexity domain of yeast Nab3. Prion (2015) 0.77
Stability of Aβ (1-42) peptide fibrils as consequence of environmental modifications. Eur Biophys J (2010) 0.76
Membrane interactions of a self-assembling model peptide that mimics the self-association, structure and toxicity of Abeta(1-40). Biochim Biophys Acta (2009) 0.76
Toward understanding amyloid aggregation. Biophys J (1995) 0.75
Biomimetic spinning of artificial spider silk from a chimeric minispidroin. Nat Chem Biol (2017) 0.75
The importance of a gatekeeper residue on the aggregation of transthyretin: implications for transthyretin-related amyloidoses. J Biol Chem (2014) 0.75
In Vitro Quantified Determination of β-Amyloid 42 Peptides, a Biomarker of Neuro-Degenerative Disorders, in PBS and Human Serum Using a Simple, Cost-Effective Thin Gold Film Biosensor. Biosensors (Basel) (2017) 0.75
The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature (1987) 17.08
Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc Natl Acad Sci U S A (1985) 16.10
Alzheimer-type neuropathology in transgenic mice overexpressing V717F beta-amyloid precursor protein. Nature (1995) 9.39
Thioflavine T interaction with synthetic Alzheimer's disease beta-amyloid peptides: detection of amyloid aggregation in solution. Protein Sci (1993) 7.92
The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease. Biochemistry (1993) 7.26
Hydration of proteins and polypeptides. Adv Protein Chem (1974) 6.25
Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides. Science (1990) 6.03
Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state. J Neurosci (1993) 4.60
beta-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. J Neurosci (1992) 4.10
Synthetic peptide homologous to beta protein from Alzheimer disease forms amyloid-like fibrils in vitro. Proc Natl Acad Sci U S A (1987) 4.04
Neuritic plaques and cerebrovascular amyloid in Alzheimer disease are antigenically related. Proc Natl Acad Sci U S A (1985) 3.54
Solution conformations and aggregational properties of synthetic amyloid beta-peptides of Alzheimer's disease. Analysis of circular dichroism spectra. J Mol Biol (1992) 3.53
Aggregation and secondary structure of synthetic amyloid beta A4 peptides of Alzheimer's disease. J Mol Biol (1991) 3.33
Structure of beta-crystallite assemblies formed by Alzheimer beta-amyloid protein analogues: analysis by x-ray diffraction. Biophys J (1993) 2.77
Apoptosis is induced by beta-amyloid in cultured central nervous system neurons. Proc Natl Acad Sci U S A (1993) 2.62
Fibril formation by primate, rodent, and Dutch-hemorrhagic analogues of Alzheimer amyloid beta-protein. Biochemistry (1992) 2.36
pH-dependent structural transitions of Alzheimer amyloid peptides. Biophys J (1991) 2.33
Beta-amyloid protein increases the vulnerability of cultured cortical neurons to excitotoxic damage. Brain Res (1990) 2.26
Differences between vascular and plaque core amyloid in Alzheimer's disease. J Neurochem (1988) 2.24
Ultrastructural morphology of amyloid fibrils from neuritic and amyloid plaques. Acta Neuropathol (1983) 2.23
Amyloid-beta aggregation: selective inhibition of aggregation in mixtures of amyloid with different chain lengths. Biophys J (1994) 1.99
Surfactant properties of Alzheimer's A beta peptides and the mechanism of amyloid aggregation. J Biol Chem (1994) 1.88
Morphology and antibody recognition of synthetic beta-amyloid peptides. J Neurosci Res (1991) 1.77
Calcium-destabilizing and neurodegenerative effects of aggregated beta-amyloid peptide are attenuated by basic FGF. Brain Res (1993) 1.74
Aggregation-related toxicity of synthetic beta-amyloid protein in hippocampal cultures. Eur J Pharmacol (1991) 1.56
Conformation and fibrillogenesis of Alzheimer A beta peptides with selected substitution of charged residues. J Mol Biol (1994) 1.52
Methodological variables in the assessment of beta amyloid neurotoxicity. Neurobiol Aging (1993) 1.35
Effect of acid predissolution on fibril size and fibril flexibility of synthetic beta-amyloid peptide. Biophys J (1994) 1.28
Beware of proteins in DMSO. Biochim Biophys Acta (1991) 1.27
Light scattering analysis of fibril growth from the amino-terminal fragment beta(1-28) of beta-amyloid peptide. Biophys J (1993) 1.25
beta-Amyloid neurotoxicity in human cortical culture is not mediated by excitotoxins. J Neurochem (1993) 1.05
Amyloid beta protein-induced neuronal cell death: neurotoxic properties of aggregated amyloid beta protein. Brain Res (1994) 1.02
Attenuation of the neurotoxic effect of A beta amyloid peptide by apolipoprotein E. Biochem Biophys Res Commun (1994) 1.01
Aggregation state-dependent binding of beta-amyloid peptide to protein and lipid components of rat cortical homogenates. Biochem Biophys Res Commun (1995) 0.88
Administration of amyloid beta-peptides into the medial septum of rats decreases acetylcholine release from hippocampus in vivo. Brain Res (1994) 0.88
Structure determination of extracellular fragments of amyloid proteins involved in Alzheimer's disease and Dutch-type hereditary cerebral haemorrhage with amyloidosis. Eur J Biochem (1994) 0.87
Physicochemical properties of aqueous xanthan solutions: static light scattering. Biopolymers (1994) 0.81
Electrophoretic techniques for the analysis of synthetic amyloid beta-A4-related peptides. Anal Biochem (1993) 0.79
A mathematical model of the kinetics of beta-amyloid fibril growth from the denatured state. Biophys J (2001) 1.96
Kinetics of aggregation of synthetic beta-amyloid peptide. Arch Biochem Biophys (1992) 1.79
Recognition sequence design for peptidyl modulators of beta-amyloid aggregation and toxicity. Biochemistry (1999) 1.45
Effect of acid predissolution on fibril size and fibril flexibility of synthetic beta-amyloid peptide. Biophys J (1994) 1.28
A strategy for designing inhibitors of beta-amyloid toxicity. J Biol Chem (1996) 1.28
Structure-function relationships for inhibitors of beta-amyloid toxicity containing the recognition sequence KLVFF. Biochemistry (2001) 1.26
Correlation of beta-amyloid aggregate size and hydrophobicity with decreased bilayer fluidity of model membranes. Biochemistry (2000) 1.26
Light scattering analysis of fibril growth from the amino-terminal fragment beta(1-28) of beta-amyloid peptide. Biophys J (1993) 1.25
S-glutathionylation of troponin I (fast) increases contractile apparatus Ca2+ sensitivity in fast-twitch muscle fibres of rats and humans. J Physiol (2012) 1.23
Chloride conductance in the transverse tubular system of rat skeletal muscle fibres: importance in excitation-contraction coupling and fatigue. J Physiol (2007) 1.17
Creatine and the creatine transporter: a review. Mol Cell Biochem (2001) 1.15
Effects of carnosine on contractile apparatus Ca²⁺ sensitivity and sarcoplasmic reticulum Ca²⁺ release in human skeletal muscle fibers. J Appl Physiol (1985) (2011) 1.10
Influence of cellular trafficking on protein synthesis inhibition of immunotoxins directed against the transferrin receptor. Cancer Res (1995) 1.08
Endogenous and maximal sarcoplasmic reticulum calcium content and calsequestrin expression in type I and type II human skeletal muscle fibres. J Physiol (2013) 1.06
Sarcoplasmic reticulum Ca2+ uptake and leak properties, and SERCA isoform expression, in type I and type II fibres of human skeletal muscle. J Physiol (2014) 1.00
Beta-amyloid peptide blocks the fast-inactivating K+ current in rat hippocampal neurons. Biophys J (1996) 0.96
Profile of changes in lipid bilayer structure caused by beta-amyloid peptide. Biochemistry (2001) 0.93
Quantitative analysis of protein synthesis inhibition by transferrin-toxin conjugates. Cancer Res (1994) 0.93
Quasi-elastic light scattering of antigen-antibody complexes. Mol Immunol (1988) 0.90
Effect of beta-amyloid block of the fast-inactivating K+ channel on intracellular Ca2+ and excitability in a modeled neuron. Proc Natl Acad Sci U S A (1996) 0.90
Coupled cellular trafficking and diffusional limitations in delivery of immunotoxins to multicell tumor spheroids. Biotechnol Bioeng (1999) 0.90
Serotonin receptor subtypes and the modulation of pain transmission. Prog Brain Res (1988) 0.89
Aggregation state-dependent binding of beta-amyloid peptide to protein and lipid components of rat cortical homogenates. Biochem Biophys Res Commun (1995) 0.88
The human early pregnancy factor/chaperonin 10 gene family. Biochem Mol Med (1996) 0.86
Pain assessment in journal of athletic training articles 1992-1998: implications for improving research and practice. J Athl Train (2000) 0.86
Intensive care unit patients with acquired immunodeficiency syndrome and Pneumocystis carinii pneumonia: suggested predictors of hospital outcome. Crit Care Med (1991) 0.83
Role of spinal serotonin1 receptor subtypes in thermally and mechanically elicited nociceptive reflexes. Psychopharmacology (Berl) (1992) 0.83
Quantitative analysis of protein synthesis inhibition and recovery in CRM107 immunotoxin-treated HeLa cells. Biotechnol Bioeng (1998) 0.82
Concentric versus enhanced eccentric hamstring strength training: clinical implications. J Athl Train (1998) 0.82
Intense exercise up-regulates Na+,K+-ATPase isoform mRNA, but not protein expression in human skeletal muscle. J Physiol (2004) 0.81
Production of a recombinant form of early pregnancy factor that can prolong allogeneic skin graft survival time in rats. Immunol Cell Biol (2000) 0.79
Templated assembly of the pH-sensitive membrane-lytic peptide GALA. J Pept Res (2004) 0.78
Design of a pH-sensitive pore-forming peptide with improved performance. J Pept Res (2004) 0.78
Kinetics of cellular trafficking and cytotoxicity of 9.2.27-gelonin immunotoxins targeted against the high-molecular-weight melanoma-associated antigen. Cancer Immunol Immunother (1999) 0.78
Mapping and characterization of the eukaryotic early pregnancy factor/chaperonin 10 gene family. Somat Cell Mol Genet (1998) 0.76
Power and gender. Can Nurse (1993) 0.75
Synthesis and characterization of membrane-active GALA-OKT9 conjugates. Bioconjug Chem (2001) 0.75
Blaming the victim. Can Nurse (1991) 0.75
The hidden epidemic. Can Nurse (1981) 0.75
Creatively teaching the interrelationships of a nursing model. Nurse Educ (1991) 0.75
Differential effects of substance P on serotonin-modulated spinal nociceptive reflexes. Psychopharmacology (Berl) (1987) 0.75
Depression is a feminist issue. Can Nurse (1985) 0.75